NASDAQ:SNPS - Synopsys Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$91.77 -0.17 (-0.18 %)
(As of 07/20/2018 04:36 AM ET)
Previous Close$91.94
Today's Range$91.55 - $92.34
52-Week Range$75.49 - $94.80
Volume750,300 shs
Average Volume1.00 million shs
Market Capitalization$13.73 billion
P/E Ratio104.28
Dividend YieldN/A
Beta1.1
Synopsys logoSynopsys, Inc. provides electronic design automation (EDA) software products used to design and test integrated circuits (ICs). It offers Galaxy Design platform that offers IC design solutions; Verification Continuum Platform, which provides virtual prototyping, static and formal verification, simulation, emulation, field-programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions. The company also offers DesignWare intellectual property (IP) solutions for USB, PCI Express, DDR, Ethernet, SATA, MIPI, HDMI, and Bluetooth low energy applications; analog IP, including data converters and audio codecs; and system-on-chip infrastructure IP, datapath and building block IP, and verification IP products, as well as mathematical and floating point components, and ARM AMBA interconnect fabric and peripherals. In addition, it provides logic libraries and embedded memories; configurable processor cores and application-specific instruction-set processor tools for embedded applications; IP subsystems for audio, sensor, and data fusion functionality; and security IP solutions. Further, the company offers Platform Architect tools for SoC architecture analysis and optimization; virtual prototyping solutions for creating virtual prototypes and virtualizers; and HAPS based prototyping systems, as well as a series of tools used in the design of optical systems and photonic devices. Additionally, it provides testing tools, services, and programs, which include security testing, managed services, programs and professional services, and training that enable its customers to detect and remediate defects in the software development lifecycle; manufacturing solutions for semiconductor manufacturers to develop fabrication processes; and professional services and others. The company has a collaboration agreement with Arm. Synopsys, Inc. was founded in 1986 and is headquartered in Mountain View, California.

Receive SNPS News and Ratings via Email

Sign-up to receive the latest news and ratings for SNPS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Prepackaged software
Sub-IndustryApplication Software
SectorComputer and Technology
SymbolNASDAQ:SNPS
CUSIP87160710
Phone650-584-5000

Debt

Debt-to-Equity Ratio0.04
Current Ratio0.73
Quick Ratio0.73

Price-To-Earnings

Trailing P/E Ratio104.28
Forward P/E Ratio55.62
P/E Growth5.58

Sales & Book Value

Annual Sales$2.72 billion
Price / Sales5.02
Cash Flow$2.1618 per share
Price / Cash42.45
Book Value$21.83 per share
Price / Book4.20

Profitability

EPS (Most Recent Fiscal Year)$0.88
Net Income$136.56 million
Net Margins3.25%
Return on Equity6.55%
Return on Assets3.81%

Miscellaneous

Employees11,686
Outstanding Shares149,010,000
Market Cap$13,725.39

Synopsys (NASDAQ:SNPS) Frequently Asked Questions

What is Synopsys' stock symbol?

Synopsys trades on the NASDAQ under the ticker symbol "SNPS."

How will Synopsys' stock buyback program work?

Synopsys announced that its Board of Directors has authorized a stock buyback program on Thursday, April 5th 2018, which permits the company to repurchase $500,000,000.00 in shares, according to EventVestor. This repurchase authorization permits the company to purchase up to 4.1% of its stock through open market purchases. Stock repurchase programs are generally a sign that the company's management believes its shares are undervalued.

How were Synopsys' earnings last quarter?

Synopsys, Inc. (NASDAQ:SNPS) posted its earnings results on Wednesday, May, 23rd. The semiconductor company reported $1.08 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $1.08. The semiconductor company earned $776.80 million during the quarter, compared to the consensus estimate of $775.60 million. Synopsys had a return on equity of 6.55% and a net margin of 3.25%. The business's quarterly revenue was up 14.2% on a year-over-year basis. During the same period in the prior year, the business posted $0.88 earnings per share. View Synopsys' Earnings History.

When is Synopsys' next earnings date?

Synopsys is scheduled to release their next quarterly earnings announcement on Tuesday, August, 14th 2018. View Earnings Estimates for Synopsys.

What guidance has Synopsys issued on next quarter's earnings?

Synopsys issued an update on its FY18 earnings guidance on Wednesday, May, 23rd. The company provided earnings per share (EPS) guidance of $3.76-3.83 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.72. The company issued revenue guidance of $3.07-3.10 billion, compared to the consensus revenue estimate of $2.94 billion.Synopsys also updated its Q3 guidance to $0.89-0.93 EPS.

What price target have analysts set for SNPS?

6 brokers have issued 1-year price targets for Synopsys' stock. Their forecasts range from $87.00 to $120.00. On average, they expect Synopsys' share price to reach $104.3333 in the next twelve months. This suggests a possible upside of 13.7% from the stock's current price. View Analyst Ratings for Synopsys.

What is the consensus analysts' recommendation for Synopsys?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Synopsys in the last year. There are currently 1 sell rating and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy."

Who are some of Synopsys' key competitors?

Who are Synopsys' key executives?

Synopsys' management team includes the folowing people:
  • Dr. Aart J. de Geus, Co-Founder, Chairman & Co-CEO (Age 64)
  • Dr. Chi-Foon Chan, Co-CEO, Pres & Director (Age 69)
  • Mr. Trac Pham, Chief Financial Officer (Age 49)
  • Mr. John F. Runkel Jr., Gen. Counsel & Corp. Sec. (Age 62)
  • Mr. Joseph W. Logan, Sales & Corp. Marketing Officer (Age 58)

Has Synopsys been receiving favorable news coverage?

Press coverage about SNPS stock has trended somewhat positive recently, according to Accern Sentiment Analysis. Accern identifies negative and positive news coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Synopsys earned a coverage optimism score of 0.11 on Accern's scale. They also gave media stories about the semiconductor company an impact score of 49.67 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the next several days.

Who are Synopsys' major shareholders?

Synopsys' stock is owned by a number of of retail and institutional investors. Top institutional investors include Swedbank (1.95%), Assenagon Asset Management S.A. (0.26%), Bank of Montreal Can (0.22%), Fisher Asset Management LLC (0.19%), Westpac Banking Corp (0.05%) and Retirement Systems of Alabama (0.05%). Company insiders that own Synopsys stock include Alfred Castino, Brian M Beattie, Chi-Foon Chan, Chrysostomos L Nikias, Geus Aart De, John F Runkel Jr, John Schwarz, Joseph W Logan, Steven Walske, Sudhindra Kankanwadi and Trac Pham. View Institutional Ownership Trends for Synopsys.

Which major investors are selling Synopsys stock?

SNPS stock was sold by a variety of institutional investors in the last quarter, including Meag Munich Ergo Kapitalanlagegesellschaft MBH, Fisher Asset Management LLC, Hartford Investment Management Co., Smith Graham & Co. Investment Advisors LP, Nisa Investment Advisors LLC, Monument Capital Management, Retirement Systems of Alabama and Contravisory Investment Management Inc.. Company insiders that have sold Synopsys company stock in the last year include Chi-Foon Chan, Chrysostomos L Nikias, John F Runkel Jr, Joseph W Logan and Steven Walske. View Insider Buying and Selling for Synopsys.

Which major investors are buying Synopsys stock?

SNPS stock was purchased by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., Swedbank, Bank of Montreal Can, Clinton Group Inc., State of Alaska Department of Revenue, Dorsey Wright & Associates, IFM Investors Pty Ltd and Atria Investments LLC. View Insider Buying and Selling for Synopsys.

How do I buy shares of Synopsys?

Shares of SNPS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Synopsys' stock price today?

One share of SNPS stock can currently be purchased for approximately $91.77.

How big of a company is Synopsys?

Synopsys has a market capitalization of $13.73 billion and generates $2.72 billion in revenue each year. The semiconductor company earns $136.56 million in net income (profit) each year or $0.88 on an earnings per share basis. Synopsys employs 11,686 workers across the globe.

How can I contact Synopsys?

Synopsys' mailing address is 690 EAST MIDDLEFIELD ROAD, MOUNTAIN VIEW CA, 94043. The semiconductor company can be reached via phone at 650-584-5000 or via email at [email protected]


MarketBeat Community Rating for Synopsys (NASDAQ SNPS)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  323 (Vote Outperform)
Underperform Votes:  239 (Vote Underperform)
Total Votes:  562
MarketBeat's community ratings are surveys of what our community members think about Synopsys and other stocks. Vote "Outperform" if you believe SNPS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SNPS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.